Le Lézard
Classified in: Health
Subjects: NPT, TDS, FVT

International Medical Ethics Conference to Feature Sham Peer Review, Announces the Association of American Physicians and Surgeons (AAPS)


TUCSON, Ariz., Nov. 19, 2018 /PRNewswire/ -- A global epidemic of attacks on ethical physicians, which endangers patients, will be a focus of the 13th UNESCO World Conference on Bioethics, Medical Ethics & Health Law, Nov 27-29, at the Ramada Hotel in Jerusalem.

(PRNewsfoto/Association of American Physici)

Lawrence Huntoon, M.D., Ph.D., will present the keynote address on "Sham Peer Review: a Worldwide Phenomenon." Dr. Huntoon, a neurologist practicing in New York, is editor-in-chief of the Journal of American Physicians and Surgeons.

Sham peer review targets physicians in a potentially career-ending administrative process, for reasons other than legitimate patient-care concerns, such as anti-competitive motives. Physicians have virtually no due-process rights in such actions.

"When a highly-skilled, compassionate physician is eliminated from a hospital as the result of sham peer review, patient safety and quality care suffer," Dr. Huntoon states.

Gil Mileikowsky, M.D., will present a talk on "How to Protect Physician Whistleblowers?Patient Advocates?from Retaliation to Benefit Patients." He was named "One of 20 People Who Make Healthcare Better" by American Health Leaders Media. A victim of sham peer review, Dr. Mileikowsky prevailed before the Supreme Court of California against the Hospital Corporation of America (HCA). Thanks to his advocacy, the State of California passed a law broadening the protection of physician whistleblowers. He is president and founder of the Alliance for Patient Safety, with resources available in English and Hebrew.

Jonathan Davies, an expert in the area of medical malpractice, will lead the session's panel about the legal and ethical implications of the ripple effects of sham peer review throughout the world of medicine. He filed a lawsuit against Hadassah hospital in November 2017 on behalf of Aviva Milgalter, widow of Dr. Eli Milgalter, a cardiac surgeon who warned about various practices endangering patients' lives from unwarranted risks. Instead of preventing such dangers, Hadassah initiated sham peer review proceedings to destroy Dr. Migalter's career, during which he died of sudden cardiac arrest. His widow testified before Knesset's Oversight Committee of Israel's Office of the Inspector General.

Eitan Meiri, an organizational psychologist, will speak about "The Silent Epidemic in the Workplace?Abuse, Bullying, Harassment, Psychological Abuse."

Registration is available online, at https://ethics-2018.isas.co.il/registration-f/, until Nov 22. Afterward, there is on-site registration.

The Association of American Physicians and Surgeons (AAPS) is a national organization representing physicians in all specialties, founded in 1943. Its motto is "omnia pro aegroto," or "all for the patient."

SOURCE Association of American Physicians and Surgeons (AAPS)


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: